GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HLB Science Inc (XKRX:343090) » Definitions » YoY EBITDA Growth

HLB Science (XKRX:343090) YoY EBITDA Growth : 0.00% (As of . 20)


View and export this data going back to 2020. Start your Free Trial

What is HLB Science YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. HLB Science's YoY EBITDA Growth for the quarter that ended in . 20 was 0.00%.

HLB Science's EBITDA per Share for the three months ended in . 20 was ₩0.00.

HLB Science YoY EBITDA Growth Historical Data

The historical data trend for HLB Science's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Science YoY EBITDA Growth Chart

HLB Science Annual Data
Trend Dec22 Dec23
YoY EBITDA Growth
- 62.91

HLB Science Quarterly Data
YoY EBITDA Growth

HLB Science YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

HLB Science's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(-116.549--314.229)/ | -314.229 |
=62.91 %

HLB Science's YoY EBITDA Growth for the quarter that ended in . 20 is calculated as:

YoY EBITDA Growth (Q: . 20 )
=(EBITDA per Share (Q: . 20 )-EBITDA per Share (Q: . 20 )) / | EBITDA per Share (Q: . 20 )) |
=(-)/ | |
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HLB Science YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of HLB Science's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

HLB Science (XKRX:343090) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HLB Science Inc (XKRX:343090) » Definitions » YoY EBITDA Growth
Comparable Companies
XKRX:950220 XKRX:283100 XKRX:322970 XKRX:215380 XKRX:179530 XKRX:446440 XKRX:251280 XKRX:208340 XKRX:344860 XKRX:072520 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
66, Achasan-ro, 6th Floor, Seongdong-gu, Seoul, KOR
Website
http://www.hlbscience.com
HLB Science Inc develops biological new drugs to treat infectious diseases. Its product pipelines includes DD-S052P, DD-A279, and DD-A514.

HLB Science (XKRX:343090) Headlines

No Headlines